Clinical pharmaceutical analysis the treatment of hypertension in patients with diabetes mellitus in the hospital Mnazi Mnoja (Zanzibar)
Treatment of arterial hypertension (AH) in patients with type II diabetes mellitus (DM) is a significant problem of practical medicine in many aspects.
In order to study the pertinence of the schemes in practice of the treatment of AH in diabetic patients with current guidelines we analyzed medical records of 348 patients aged 38 to 70 years (mean age, 49 ± 0,43 years), corresponding to the criteria in the hospital named after V.I. Lenin (Mnazi Mmoja) Zanzibar (Tanzania). The investigated were divided into two groups matched for age and sex composition of the groups. The first group consisted of 301 patients with a combination of AH and DM (study group), and the second one (control) consisted of 47 hypertensive patients without DM.
It has been found the preference to use of converting enzyme (ACE) inhibitors, respectively 83.1% and 91.5% according to the groups. In the group of the study was much larger variation of combinations of drugs, which is comparable with the existing guidelines of prescribing medicines according to the state of the target organs. The prevailing use of a combination of an ACE inhibitor, calcium channel blocker and diuretic (69.4%). There was irrational look because of absence in the arsenal of drugs non- dihydropyridine calcium channel blockers, modern beta-blockers (bisoprolol, carvedilol) and the widespread use of thiazide diuretics as monotherapy use against DM.
Based on the completed research the practical recommendations involved phasing of antihypertensive drugs prescription (angiotensin-converting enzyme inhibitor or a non- dihydropyridine calcium channel blocker, and then adding of the other preparations due to the therapeutic effect).
Key words: arterial hypertension, diabetes mellitus, medication, rational treatment.
How to Cite
LicenseAuthors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)